TRODAT SPECT in patients with idiopathic REM sleep behaviour disorder

Geraldo Nunes Vieira Rizzo
DOI: https://doi.org/10.5935/1984-0063.20180014
2018-01-01
Sleep Science
Abstract:to determine the value of dopamine transporter (DAT) neuroimaging radiotracer in a group of idiopathic rapid eye movement sleep behavior disorder (iRBD) patients regarding the development of a synucleinopathy. <b>Methods:</b> 6 retrospectively selected patients with clinical and polysomnographic diagnosis of iRBD, on treatment or not, were submitted to a single-photon emission computerized tomography (SPECT) with TRODAT. <b>Results:</b> Five from six patients have an abnormal test showing reduction in DAT density measured by the linkage potential on SPECT. <b>Conclusions:</b> TRODAT crosses the blood brain barrier, has a high affinity for DAT and is capture by SPECT. The decreased uptake of DAT tracers means a reduction in dopaminergic activity which suggest the possibility of Parkinson Disease. We have tried to reinforce iRBD as a marker of neurodegenerative disease and suggest SPECT with TRODAT as an easy method in our country to follow longitudinally these patients.
What problem does this paper attempt to address?